Natural Antioxidant Ice-cream, Oxidative Stress and Vascular Function

Sponsor
University of Roma La Sapienza (Other)
Overall Status
Completed
CT.gov ID
NCT02685163
Collaborator
(none)
14
2
5

Study Details

Study Description

Brief Summary

Formation of reactive oxygen species (ROS) contributes to pathogenesis and progression of several diseases. Polyphenols, have been shown to be beneficial against ROS.

This study evaluate the effects of a natural antioxidant ice-cream,rich in polyphenols, on oxidative stress, vascular function and physical performance. In this controlled, single-blind cross-over study, 14 healthy subjects were randomized to assume 100 mg of antioxidant ice-cream consisting of dark cocoa powder, extract of hazelnut and green tea, or milk chocolate ice-cream (control ice-cream). Subjects were studied at baseline and two hours after the ingestion of the ice-creams. Serum polyphenols, antioxidant status (ferric reducing ability of plasma, FRAP), NO bioavailability (NOx), markers of oxidative stress (D-Roms and H2O2), endothelium function (FMD and RHI) and exercise tolerance (Stress Test) with measurement of the double product were assessed.

Condition or Disease Intervention/Treatment Phase
  • Other: Antioxidant ice-cream
  • Other: Control Ice-cream
N/A

Detailed Description

14 healthy, non-smoking, volunteers (7 males ), aged between 20 and 40 years were enrolled. The study was randomized, placebo-controlled. After enrollment, 3 days before entering the study, all subjects performed an exercise stress test. They were then randomly allocated to the treatment sequence with 100 mg of natural anti-oxidant ice cream or milk chocolate ice-cream (control icecream) in a cross-over single-blind design. There was 1 week wash-out between 2 phases of the study.

Markers of oxidative stress (D-ROMs and H2O2); serum antioxidant status (FRAP), NO bioavailability (NOx), the endothelium flow-mediated vasodilation (FMD and the RHI by Endopat 2000) were evaluated in fasting condition at baseline (time 0) and 2 hours after the ingestion of the anti-oxidant or control ice-creams. The exercise stress test was performed before randomization and 2 hours after each ice-cream meal test. In both experiments, the ice-cream was consumed within 10 min.

Each subject was asked to refrain from any kind of medication, diet integrators, intensive physical activity and to avoid consumption of polyphenols rich foods, such cocoa-containing products, red wine, tea within the previously 2 weeks. All participants gave written informed consent, and the study was approved by the Medical Ethics Committee of La Sapienza University of Rome (Rif: 3727, Prot: 2325/15).

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Natural Antioxidant Ice-cream Acutely Reduces Oxidative Stress, Improves Vascular Function and Physical Performance in Healthy Subjects
Study Start Date :
Jul 1, 2015
Actual Primary Completion Date :
Oct 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Antioxidant Ice-cream

Natural antioxidant Ice-cream

Other: Antioxidant ice-cream
Narutal Antioxidant ice-cream

Placebo Comparator: Control Ice-cream

Natural control ice-cream

Other: Control Ice-cream
Natural Control Ice-cream

Outcome Measures

Primary Outcome Measures

  1. Endothelial function [Acute 2 hours]

    Endothelial function will be performed By Endopat2000 and FMD

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy, non-smoking, volunteers
Exclusion Criteria:
  • Assumption of any kind of medication, diet integrators, intensive physical activity and to avoid consumption of polyphenols rich foods, tea within the previously 2 weeks.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Roma La Sapienza

Investigators

  • Principal Investigator: Davide Francomano, MD, Sapienza University of Rome

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Davide Francomano, PhD Researcher, University of Roma La Sapienza
ClinicalTrials.gov Identifier:
NCT02685163
Other Study ID Numbers:
  • Rif: 3727, Prot: 2325/15
First Posted:
Feb 18, 2016
Last Update Posted:
Feb 19, 2016
Last Verified:
Feb 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 19, 2016